Sanofi and Translate Bio collaborate to develop novel mRNA vaccine candidate against COVID-19

NEXT STORY
Eton Pharmaceuticals Announces Acquisition of U.S Marketing Rights to Pediatric Orphan Drug Alkindi® Sprinkle
PREV STORY
Translate Bio Provides MRT5005 Program Updates
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Presentations at ASN Kidney Week 2019 Highlight Breadth of ChemoCentryx Platform in Treatment of Complement 3 Glomerulopathy (C3G) and Focal Segmental Glomerulosclerosis (FSGS)

author_avatar
NASDAQ Market News

Tetra Bio-Pharma Names Vice-President, Clinical Programs and Medical Affairs to Its Leadership Team

author_avatar
NASDAQ Market News

Forty Seven, Inc. and Ono Pharmaceutical Co., Ltd. Sign Regional License Agreement to Develop, Manufacture and Commercialize 5F9 in Japan, South Korea, Taiwan and Select Countries in Southeast Asia

author_avatar
NASDAQ Market News